Medical/Pharmaceuticals
Seegene Reinforces Commitment to Strong ESG Management with 100% Recyclable, Styrofoam-Free Shipping Boxes
* 100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations * Patent design provides a 30% increase in load capacity and an up to 52% reduction in transportation costs * This initiative is part of Seegene's effort...
2023-10-18 19:00
3169
Telix reports fourth consecutive quarter of positive operating cash flow
MELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended30 September 2023 (Q3 2023). All figures are in AUD$ unless otherwise s...
2023-10-18 15:42
2590
Yuyu Pharma to attend 'CPHI Worldwide 2023'
SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending
CPHI Worldwide inBarcelona, Spain from October 24th to October 26th.
2023-10-18 15:00
7452
Aculys Pharma delivers positive Phase 3 clinical study interim analysis result of a diazepam nasal spray: an antiepileptic drug for the treatment of epileptic seizures
* These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered antiepileptic drug for Japanese patients aged 6 to 17 for the treatment of status epilepticus or epileptic seizures that may lead to status epilepticus. * The primary efficacy endpoint was...
2023-10-18 14:00
2134
Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative
BANGKOK, Oct. 18, 2023 /PRNewswire/ -- "I have a dream that everyone should have the ability to access medical care equally," says Oraphan Wanacharoen (Ice), BGI Genomics Field Application Scientist. "It's very challenging to achieve such a goal inThailand. With the advanced technology of the com...
2023-10-18 08:21
3728
New Results From HEALEY ALS Platform Trial Show Promise for Treating ALS
MONTREAL, Oct. 18, 2023 /PRNewswire/ -- One of the central challenges of Amyotrophic Lateral Sclerosis ALS research is finding ways to slow the progression of the relentlessly degenerative brain disease. Recently, based on results of theHEALEY ALS Platform Trial, two experimental medications plan...
2023-10-18 03:04
2083
Neurologist Anthony Lang Presents Groundbreaking News on Parkinson's Disease at World Congress of Neurology 2023
MONTREAL, Oct. 18, 2023 /PRNewswire/ -- During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research,University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinso...
2023-10-18 02:59
2197
Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion
SAN DIEGO and SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Bio4t2® received regulatory approvals to repeatedly administer patients with T cells engineered to express a chimeric antigen receptor (CAR) targeting BT-001, an antigen on solid tumors identified using the PrismCore™ platform. The CAR-T, term...
2023-10-17 23:17
3120
SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
ZUG, Switzerland, Oct. 17, 2023 /PRNewswire/ -- SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedica...
2023-10-17 17:00
5797
Docquity pioneers the first regional job platform focused on Southeast Asia's healthcare professionals
* Docquity Jobs enables healthcare organizations to access the region's largest database of medical talent across different specialities * In just one year, the job portal has expanded to four countries with around 400 employers on board * Docquity Jobs has seen a 30% month-on-month growth...
2023-10-17 10:00
4486
World Health Organization Presents Global Action Plan for Neurological Disorders at World Congress of Neurology
MONTREAL, Oct. 16, 2023 /PRNewswire/ -- The World Health Organization (WHO) revealed its new Intersectoral Global Action Plan (IGAP), a critical blueprint for combating neurological conditions that calls for urgent action from governments and health care organizations around the world. IGAP outli...
2023-10-16 22:50
2329
Hong Kong Breast Cancer Foundation - "Pink Walk 2023" Charity Walk Concluded Successfully
Nearly 2,000 Pink Walkers returned to the Peak for Step Up for Breast Health HONG KONG, Oct. 16, 2023 /PRNewswire/ -- The annual flagship fundraising event, "Pink Walk 2023" organised by the Hong Kong Breast Cancer Foundation (HKBCF), was successfully held on 15 October in the Breast Cancer Aware...
2023-10-16 21:01
2952
Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia's In-Vitro Diagnostics Industry
JAKARTA, Indonesia, Oct. 16, 2023 /PRNewswire/ -- On October 12th, 2023, Fapon, a leading life-science organization, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform inIndonesia. This partnership brings together Fapon's expertise in in-vitro diagnostics (IVD)...
2023-10-16 15:29
4022
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis
SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug Administration (FDA) for VELSIPITY™ (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (...
2023-10-16 07:48
3088
UEG Week 2023: Babies with a low birthweight four times more likely to develop fatty liver disease in later life
COPENHAGEN, Denmark, Oct. 16, 2023 /PRNewswire/ -- A groundbreaking new study, presented today at UEG Week 2023, has discovered a significant connection between birthweight and the onset of nonalcoholic fatty liver disease, now known as metabolic dysfunction-associated steatotic liver disease (MA...
2023-10-16 06:01
3906
HEALTHSCOPE : AI ENABLES PATIENT EMOTIONS TO BE ANALYSED IMPROVING HOSPITAL EXPERIENCE.
MELBOURNE, Australia, Oct. 16, 2023 /PRNewswire/ -- A new way to capture patients' emotions is being pioneered by Healthscope to improve how they deliver patient experience following a 3-year study, in what is believed to be a world first by a private hospital. Hospitals rely every day on data s...
2023-10-16 04:00
3295
Offering broader access to sustainable and scalable pharma-grade saponin adjuvants
SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment to expand Q-Vant's proprietary 100% sustainable Q-SAP™ technology, and the signing of an exclusive commercial agreement to accelerate global adoption of their high-purity saponin adjuvants ...
2023-10-13 21:47
3336
World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide
CHAPEL HILL, N.C., Oct. 13, 2023 /PRNewswire/ -- Today is World Thrombosis Day, a global effort by the International Society on Thrombosis and Haemostasis (ISTH) to spread awareness of the signs, symptoms and risk factors of thrombosis, commonly known as blood clots. World Thrombosis Day engages...
2023-10-13 15:00
1379
GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS
SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Recently, ABL Bio, a partner of GenScript ProBio, announced the Ministry of Food and Drug Safety (MFDS) cleared of its clinical trial application for innovative bispecific antibody program (B7H4x4-1BB) in solid tumor. GenScript ProBio warmly exten...
2023-10-13 09:00
3974
M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare
ABU DHABI, UAE, Oct. 13, 2023 /PRNewswire/ -- M42, a global tech-enabled healthcare network, has unveiled an impactful advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM). The 70 billion parameter, generative artificial intelligence...
2023-10-13 01:26
3524
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 307 media titles]
2026-10-27 13:40
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 296 media titles]
2026-10-22 22:35
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 278 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
36572
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
35733
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
34483
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
28871
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
17778
